(Q33397694)

26 July 2017

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

26 July 2017

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

hepatocellular carcinoma

1 reference

Tetsuya Hosaka

6

0 references

Hiromitsu Kumada

16

object named as

Hiromitsu Kumada

1 reference

26 July 2017

11

Fumitaka Suzuki

1 reference

26 July 2017

3

Kenji Ikeda

1 reference

26 July 2017

7

Masahiro Kobayashi

1 reference

26 July 2017

12

Yoshiyuki Suzuki

1 reference

26 July 2017

10

Norio Akuta

1 reference

26 July 2017

2

Yasuji Arase

1 reference

26 July 2017

9

Hitomi Sezaki

1 reference

26 July 2017

8

Satoshi Saitoh

1 reference

26 July 2017

1

Yusuke Kawamura

1 reference

26 July 2017

Yuya Seko

4

1 reference

26 July 2017

Norihiro Imai

5

1 reference

26 July 2017

Yuki Ohmoto

13

1 reference

26 July 2017

Kazuhisa Amakawa

14

1 reference

26 July 2017

Hiroshi Tsuji

15

1 reference

26 July 2017

language of work or name

English

0 references

publication date

18 October 2011

1 reference

The American Journal of Gastroenterology

26 July 2017

1 reference

26 July 2017

107

1 reference

26 July 2017

2

1 reference

26 July 2017

253-261

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2011.327

26 July 2017

0 references

cites work

Epidemiology of primary liver cancer

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Cirrhosis and the aetiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Global challenges in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Epidemiology of non-alcoholic fatty liver disease in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Liver diseases and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Identification of individuals with insulin resistance using routine clinical measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Chronic liver injury during obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Designs for group sequential tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.327

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.327

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference